Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study

[1]  E. Vynnycky,et al.  The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals , 2020, Philosophical Transactions of the Royal Society B.

[2]  Sarah K. Helman,et al.  Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset , 2020, eLife.

[3]  Ganna Rozhnova,et al.  Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study , 2020, The Lancet Public Health.

[4]  D. O’Neill,et al.  Asymptomatic carriage rates and case-fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes , 2020, medRxiv.

[5]  S. Bhatt,et al.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe , 2020, Nature.

[6]  E. Lau,et al.  Evolution of effective serial interval of SARS-CoV-2 by non-pharmaceutical interventions , 2020, Research square.

[7]  F. Yu,et al.  Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset , 2020, European Respiratory Journal.

[8]  M. Drayson,et al.  SARS-CoV-2 seroconversion in health care workers , 2020, medRxiv.

[9]  Sarah K. Helman,et al.  Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection , 2020, medRxiv.

[10]  M. E. Kretzschmar,et al.  Time is of the essence: impact of delays on effectiveness of contact tracing for COVID-19 , 2020, medRxiv.

[11]  L. Kucirka,et al.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure , 2020, Annals of Internal Medicine.

[12]  William L. Hamilton,et al.  Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission , 2020, medRxiv.

[13]  Periodic COVID-19 Testing in Emergency Department Staff , 2020, medRxiv.

[14]  J. Moon,et al.  COVID-19: PCR screening of asymptomatic health-care workers at London hospital , 2020, The Lancet.

[15]  Hannah Fry,et al.  Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[16]  Yongsheng Wu,et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[17]  Jose Lourenco,et al.  Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR , 2020, medRxiv.

[18]  Y. Wen,et al.  Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.

[19]  Yan Peng,et al.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.

[20]  V. Demicheli,et al.  The early phase of the COVID-19 outbreak in Lombardy, Italy , 2020, 2003.09320.

[21]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[22]  Eric H. Y. Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[23]  Ruiyun Li,et al.  Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) , 2020, Science.

[24]  Christl A. Donnelly,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[25]  Lucie Abeler-Dörner,et al.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.

[26]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[27]  Yongsheng Wu,et al.  Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts , 2020, medRxiv.

[28]  G. Chowell,et al.  Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  L. Meyers,et al.  The serial interval of COVID-19 from publicly reported confirmed cases , 2020, medRxiv.

[30]  W. Edmunds,et al.  Incidence and risk factors for influenza-like-illness in the UK: online surveillance using Flusurvey , 2014, BMC Infectious Diseases.

[31]  Ralph S. Baric,et al.  A decade after SARS: strategies for controlling emerging coronaviruses , 2013, Nature Reviews Microbiology.

[32]  N. Grassly,et al.  Mathematical models of infectious disease transmission , 2008, Nature Reviews Microbiology.